Digg StumbleUpon LinkedIn YouTube Flickr Facebook Twitter RSS Reset
Comments Off

HEMATOLOGY MCQ – Exercise 19

The multiple choice questions in this online test paper focuses on HEMATOLOGY MCQ. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online HEMATOLOGY MCQ Test Paper will help you to evaluate your exam preparation.

Instruction for REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs:

1- This online MCQ practice test paper contains 30 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. regarding myelophthisis true statement includes

 
 
 
 

Q 2. true regarding pathogenesis of polycythemia vera

 
 
 
 

Q 3. thrombosis in polycythemia vera is due to

 
 
 
 

Q 4. bone marrow in myelodysplasia may show all except

 
 
 
 

Q 5. regarding myelophthisis true statement includes

 
 
 
 

Q 6. false about JAK2

 
 
 
 

Q 7. following do not use the JAK-STAT pathway as their essential mode of signalling

 
 
 
 

Q 8. true regarding polycythemia vera

 
 
 
 

Q 9. spurious erythrocytosis is also called as

 
 
 
 

Q 10. most frequent class in WHO estimated proportion of patients with MDS

 
 
 
 

Q 11. following illustrates the mutation in JAK2 in the pathogenesis of polycythemia vera

 
 
 
 

Q 12. following conditions can transform into each other

 
 
 
 

Q 13. following cause microcytic erythrocytosis

 
 
 
 

Q 14. chronic primary myelofibrosis characterized by all except

 
 
 
 

Q 15. intractable generalized pruritis in polycythemia vera responds to

 
 
 
 

Q 16. characteristic feature of myeloproliferative disorders

 
 
 
 

Q 17. regarding polycythemia vera all are true except

 
 
 
 

Q 18. normal range for plasma erythropoietin is

 
 
 
 

Q 19. Anagrelide is a

 
 
 
 

Q 20. JAK2 V16F is present in what percentage of PMF patients

 
 
 
 

Q 21. following typically distinguishes polycythemia vera from other causes of erythrocytosis

 
 
 
 

Q 22. false about MDS

 
 
 
 

Q 23. Philadelphia negative myeloproliferative disorders

 
 
 
 

Q 24. in secondary MDS latent period following cancer treatments is least with following which of the

 
 
 
 

Q 25. in MDS prognosis strongly correlates with

 
 
 
 

Q 26. skin condition related to MDS

 
 
 
 

Q 27. following conditions can transform into each other

 
 
 
 

Q 28. following drugs has role in the treatment of MDS

 
 
 
 

Q 29. MDS includes

 
 
 
 

Q 30. JAK2 gene is located on the

 
 
 
 


Comments are closed.